Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trial

International Journal of Hematology

Volumn 78, Issue 2, 2003, Pages 133-138

  Ahn, Myung Ju ^a   Choi, Jung Hye ^a   Lee, Young Yeul ^a   Choi, Il Young ^a   Kim, In Soon ^a   Yoon, Sung Soo ^b   Park, Sun Yang ^b   Kim, Byung Kook ^b   Suh, Cheolwon ^c   Son, Hee Jeong ^c   Jung, Cheol Won ^d   Lee, Jae Hoon ^e   Sung, Ju Myung ^f   Im, Suck Ah ^f   Oh, Doyeun ^g   Jung, So Young ^g   Yoon, Hwi Joong ^h   Cho, Kyung Sam ^h   Lee, Jung Ae ⁱ   Yuh, Young Jin ^j   Kim, Sung Rok ^j   Ki, Moran ^k   more..

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Sungkyunkwan University   (South Korea)

^e Department of Internal Medicine   (South Korea)

^f Ewha Womans University   (South Korea)

^g CHA University   (South Korea)

^h Kyung Hee University   (South Korea)

ⁱ Hallym University   (South Korea)

^j Inje University College of Medicine   (South Korea)

^k Eulji University   (South Korea)

more..

Author keywords

Adult aplastic anemia; Bone marrow transplantation; Immunosuppressive therapy

Indexed keywords

ANTIHISTAMINIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PARACETAMOL; THYMOCYTE ANTIBODY;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PROGNOSIS; RECURRENCE RISK; RELAPSE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0042389767     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983381     Document Type: Article

References (16)

1. Barrett AJ, Young NS. The treatment of severe acquired aplastic anemia. Blood. 1995;85:3367-3377.
2. Deeg HJ, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91: 3637-3645.
3. Passweg JR, Socie G. Hinterberger W, et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood. 1997;90:858-864.
4. Socie G, Stone JV, Wingard JR. et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: implications for cure. N Engl J Med. 1999;341:14-21.
5. Champlin R, Ho W, Gale RP. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med. 1983;308:113-118.
6. Doney K, Pepe M, Storb R, et al. Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-doe methylprednisolone, and oxymetholone. Blood. 1992;79:2566-2571.
7. Frickhofen N, Joachim PK, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med. 1991;324:1297-1304.
8. Marsh J, Schrezenmeier H, Marin P, et al. Prospective randomized multicenter study comparing cyclosporine alone versus the combination of antithymocyte globulin and cyclosporine for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anemia Working Party. Blood. 1999;93:2191-2195.
9. McGlave PB, Haake R, Miller W, Kim T, Kersey J, Ramsay NK. Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation. Blood. 1987;70:1325-1330.
10. Sanders JE, Storb R, Anasetti C, et al. Marrow transplant for children with severe aplastic anemia. Am J Pediatr Hematol Oncol. 1994;16:43-49.
11. Kaplan EL, Meier P. Non-parametric estimation for incomplete observation. J Am Stat Assoc. 1958;53:457.
12. Paquette RL, Tebyani N, Frane M, et al. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 1995;85:283-290.
13. Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Ann Intern Med. 1997;126:107-115.
14. Marsh JCW, Hows JM, Bryett KA, et al. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. Blood. 1987;70:1046-1052.
15. Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow transplantation versus immunosuppression for the treatment of severe aplastic anemia (SAA): a report of the EBMT SAA Working Party. Br J Haematol. 1988;70:177-182.
16. Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anemia Working Party. N Engl J Med. 1993;329:1152-1157.